Canada markets closed

Evome Medical Technologies Inc. (LNDZF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.21000.0000 (0.00%)
At close: 01:45PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-02-28
2021-02-28
Total Revenue
62,627
62,627
18,312
18,312
Cost of Revenue
40,094
40,094
12,350
12,350
Gross Profit
22,533
22,533
5,962
5,962
Operating Expenses
Selling General and Administrative
24,156
24,156
5,728
9,571
Total Operating Expenses
28,665
28,665
6,570
10,413
Operating Income or Loss
-6,132
-6,132
-607.946
-4,451
Interest Expense
2,640
2,640
388.065
388.065
Total Other Income/Expenses Net
-6,774
-6,774
-3,478
365.109
Income Before Tax
-15,546
-15,546
-4,474
-4,474
Income Tax Expense
57.069
57.069
-101.617
-101.617
Income from Continuing Operations
-15,603
-15,603
-4,372
-4,372
Net Income
-15,603
-15,603
-4,372
-4,372
Net Income available to common shareholders
-15,603
-15,603
-4,372
-4,372
Basic EPS
-0.28
-0.21
-0.10
-0.10
Diluted EPS
-0.28
-0.21
-0.10
-0.10
Basic Average Shares
53,456
73,472
43,627
43,627
Diluted Average Shares
53,456
73,472
43,627
43,627